Wei Ruan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 13

Top Topics

Vascular Endothelial Growth Factor

Coronary Artery

Magnetic Resonance

Top Venues

Nature reviews. Drug discovery

Research square

Nature cell biology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Agnieszka K Czopik, Eóin N McNamee, Victoria Vaughn, Xiangsheng Huang, In Hyuk Bang, Trent Clark, Yanyu Wang, Wei Ruan, Tom T Nguyen, Joanne C Masterson, Eunyoung Tak, Sandra Frank, Colm B Collins, Howard Li, Cristian Rodríguez-Aguayo, Gabriel Lopez-Berestein, Mark E Gerich, Glenn T Furuta, Xiaoyi Yuan, Anil K Sood, Edwin F de Zoeten, Holger K Eltzschig
HIF-2α-dependent induction of miR-29a restrains T H 1 activity during T cell dependent colitis. Nature communications 15 (1) (2024)
Wei Ruan, Tao Li, Jaewoong Lee, In Hyuk Bang, Wankun Deng, Xinxin Ma, Seung-Hee Yoo, Boyun Kim, Jiwen Li, Xiaoyi Yuan, Yu A An, Yin-Ying Wang, Yafen Liang, Matthew Deberge, Dongze Zhang, Zhen Zhou, Yanyu Wang, Joshua M Gorham, Jonathan G Seidman, Christine E Seidman, Sary F Aranki, Ragini Nair, Lei Li, Jagat Narula, Zhong-Ming Zhao, Alemayehu Abebe Gorfe, Jochen Daniel Muehlschlegel, Kuang-Lei Tsai, Holger K Eltzschig
The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury. Research square (2024)
Holger K Eltzschig, Wei Ruan, Tao Li, Jaewoong Lee, In Hyuk Bang, Wankun Deng, Xinxin Ma, Seung-Hee Yoo, Boyun Kim, Jiwen Li, Xiaoyi Yuan, Yu An, Yin-Ying Wang, Yafen Liang, Matthew Deberge, Dongze Zhang, Zhen Zhou, Yanyu Wang, Joshua M Gorham, Jonathan G Seidman, Christine E Seidman, Sary Aranki, Ragini Nair, Lei Li, Jagat Narula, Zhong-Ming Zhao, Alemayehu Abebe Gorfe, Jochen Muehlschlegel, Kuang-Lei Tsai
The BMAL1/HIF2A heterodimer modulates circadian variations of myocardial injury. Research square (2024)
Wei Ruan, Holger K Eltzschig, Xiaoyi Yuan
Hypoxia-stabilized RIPK1 promotes cell death. Nature cell biology (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery 23 (3) (2023)
Xiaoyi Yuan, Wei Ruan, Bentley Bobrow, Peter Carmeliet, Holger K Eltzschig
Targeting hypoxia-inducible factors: therapeutic opportunities and challenges. Nature reviews. Drug discovery (2023)